| pubmed-article:10443326 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C0422792 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C0314603 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C1333525 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C0018301 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C1880177 | lld:lifeskim |
| pubmed-article:10443326 | lifeskim:mentions | umls-concept:C1332838 | lld:lifeskim |
| pubmed-article:10443326 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10443326 | pubmed:dateCreated | 1999-9-30 | lld:pubmed |
| pubmed-article:10443326 | pubmed:abstractText | We studied by PCR-RFLP 6 polymorphisms in these 5 candidate genes: Ala54Thr in the fatty acid binding protein 2 gene (FABP2), A to G substitution in the uncoupling protein type 1 gene (UCP1), Asp905Tyr in the protein phosphatase type 1 gene (PP1G), Trp64Arg in the human beta 3 adrenergic receptor gene (beta 3AR) and 2 RFLP sites of the vitamin D receptor (VDR) gene (VDRTaq1 and VDRApa1). This study was conducted among 89 cases and 100 controls matched according to age, gender and absence of first degree family link (11 triplets with 2 controls for 1 case and 78 pairs with 1 control for 1 case). Cases and controls were taken among a sample of 429 individuals selected for the study of the prevalence of diabetes in this ethnic group from Guadeloupe. By conditional logistic regression analysis, there was a significant relation (p = 0.02) between the Ala54Thr FABP2 polymorphism and Type 2 DM. Multivariate analysis discriminate the FABP2 polymorphism (p = 0.10), a triglyceridemia over 2 g/l (p < 10(-3)) and high blood pressure (p = 10(-2)) as variables associated with Type 2 DM in this population. These findings suggest that FABP2 does not represent a major gene for Type 2 DM in this migrant Indian population living in Guadeloupe, but seems to be related to the metabolic insulin resistance syndrome. | lld:pubmed |
| pubmed-article:10443326 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10443326 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10443326 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10443326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10443326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10443326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10443326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10443326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10443326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10443326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10443326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10443326 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10443326 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10443326 | pubmed:issn | 1262-3636 | lld:pubmed |
| pubmed-article:10443326 | pubmed:author | pubmed-author:PingetMM | lld:pubmed |
| pubmed-article:10443326 | pubmed:author | pubmed-author:SchafferPP | lld:pubmed |
| pubmed-article:10443326 | pubmed:author | pubmed-author:DonnetJ PJP | lld:pubmed |
| pubmed-article:10443326 | pubmed:author | pubmed-author:HedelinGG | lld:pubmed |
| pubmed-article:10443326 | pubmed:author | pubmed-author:FroguelPP | lld:pubmed |
| pubmed-article:10443326 | pubmed:author | pubmed-author:LeprêtreFF | lld:pubmed |
| pubmed-article:10443326 | pubmed:author | pubmed-author:Boullu-Sanchi... | lld:pubmed |
| pubmed-article:10443326 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10443326 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:10443326 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10443326 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10443326 | pubmed:pagination | 150-6 | lld:pubmed |
| pubmed-article:10443326 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:meshHeading | pubmed-meshheading:10443326... | lld:pubmed |
| pubmed-article:10443326 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10443326 | pubmed:articleTitle | Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism. | lld:pubmed |
| pubmed-article:10443326 | pubmed:affiliation | Service Endocrinologie et Maladies de la Nutrition, Hôpitaux Universitaires de Strasbourg. | lld:pubmed |
| pubmed-article:10443326 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10443326 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10443326 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10443326 | lld:pubmed |
